Steve Scala

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Steve Scala works at COWEN and is focused on the Healthcare sector with 153 price targets and ratings documented since 2013 spanning on 11 stocks. Analyst's average stock valuation to be materialised ratio is 74.33% with an average time for price targets to be met of 620.6 days.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 05-Dec-2022.

Steve Scala best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/24/2018. The price target of $95 was fulfilled within 113 days with a profit of $21.65 (29.52%) receiving and performance score of 2.61.

Average potential price target upside

of $26.65 (37.15%) on ABBV (ABBVIE INC).
of $23.1 (24.23%) on LLY (ELI LILLY AND COMPANY).
of $18.7 (44.74%) on BMY (BRISTOL-MYERS SQUIBB COMPANY).

Currently, out of the existing stock ratings of Steve Scala - 7227 which are a Buy (68.08%), 3120 which are a Hold (29.39%), 269 which are a Sell (2.53%)